Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00661804 · ClinicalTrials.gov registry record
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
A clinical trial, sponsored by Carelon Research.
- Completed
- Registry status
- 416
- Enrollment target
NCT00661804: Completed study, sponsored by Carelon Research.
NCT00661804 is a clinical trial that has completed, run by Carelon Research. The registered enrollment target is 416 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00661804 has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- 416 participants
- Enrollment target
Study Summary
Thalassemias are inherited blood disorders that can cause anemia and other health problems. The goal of this study is to collect information on complications of the disease among people who currently have or previously had thalassemia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2007-05 |
| Est. Completion | 2011-06 |
What the finished NCT00661804 record still lists
NCT00661804 is an observational study that tracks outcomes without assigning an intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00661804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00661804 about?
NCT00661804 is a clinical study titled "Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study". Thalassemias are inherited blood disorders that can cause anemia and other health problems. The goal of this study is to collect information on complications of the disease among people who currently have or previously had thalassemia.
What is the current status of trial NCT00661804?
This trial is currently completed. The enrollment target is 416 participants. The study started on 2007-05. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT00661804?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia